Correlogic, FDA To Discuss Status Of OvaCheck Ovarian Cancer Test
This article was originally published in The Gray Sheet
Executive Summary
FDA is requesting a meeting with Correlogic Systems to clarify the regulatory path to market for the OvaCheck early-stage ovarian cancer test